S&P 500   4,592.41 (-1.35%)
DOW   34,632.41 (-1.43%)
QQQ   394.26 (-1.36%)
AAPL   163.94 (+2.31%)
MSFT   331.12 (-1.64%)
FB   327.49 (-3.12%)
GOOGL   2,850.95 (-2.05%)
AMZN   3,508.17 (-1.50%)
TSLA   1,132.11 (-0.43%)
NVDA   322.53 (-3.36%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.46 (-5.42%)
AMD   157.27 (-2.87%)
GE   94.86 (-3.60%)
MU   84.83 (-1.52%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,592.41 (-1.35%)
DOW   34,632.41 (-1.43%)
QQQ   394.26 (-1.36%)
AAPL   163.94 (+2.31%)
MSFT   331.12 (-1.64%)
FB   327.49 (-3.12%)
GOOGL   2,850.95 (-2.05%)
AMZN   3,508.17 (-1.50%)
TSLA   1,132.11 (-0.43%)
NVDA   322.53 (-3.36%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.46 (-5.42%)
AMD   157.27 (-2.87%)
GE   94.86 (-3.60%)
MU   84.83 (-1.52%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,592.41 (-1.35%)
DOW   34,632.41 (-1.43%)
QQQ   394.26 (-1.36%)
AAPL   163.94 (+2.31%)
MSFT   331.12 (-1.64%)
FB   327.49 (-3.12%)
GOOGL   2,850.95 (-2.05%)
AMZN   3,508.17 (-1.50%)
TSLA   1,132.11 (-0.43%)
NVDA   322.53 (-3.36%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.46 (-5.42%)
AMD   157.27 (-2.87%)
GE   94.86 (-3.60%)
MU   84.83 (-1.52%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,592.41 (-1.35%)
DOW   34,632.41 (-1.43%)
QQQ   394.26 (-1.36%)
AAPL   163.94 (+2.31%)
MSFT   331.12 (-1.64%)
FB   327.49 (-3.12%)
GOOGL   2,850.95 (-2.05%)
AMZN   3,508.17 (-1.50%)
TSLA   1,132.11 (-0.43%)
NVDA   322.53 (-3.36%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.46 (-5.42%)
AMD   157.27 (-2.87%)
GE   94.86 (-3.60%)
MU   84.83 (-1.52%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
OTCMKTS:BCYP

Big Cypress Acquisition News Headlines

$8.44
-2.01 (-19.23%)
(As of 10/22/2021)
Add
Compare
Today's Range
$8.21
$12.90
50-Day Range
$8.44
$10.47
52-Week Range
$8.21
$12.90
Volume
15.34 million shs
Average Volume
160,982 shs
Market Capitalization
$124.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Media Mentions By Week



Big Cypress Acquisition Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCYP
News Sentiment

0.00

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCYP Articles
This Week

0

0

BCYP Articles
Average Week

Get Big Cypress Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCYP and its competitors with MarketBeat's FREE daily newsletter.

Big Cypress Acquisition (OTCMKTS:BCYP) News Headlines Today

SourceHeadline
finance.yahoo.com logoBig Cypress Acquisition Corp. Stockholders Approve Business Combination with SAB Biotherapeutics
finance.yahoo.com - October 21 at 8:30 AM
finance.yahoo.com logoSAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19
finance.yahoo.com - October 4 at 10:24 AM
finance.yahoo.com logoSAB Biotherapeutics Appoints Russell Beyer Chief Financial Officer
finance.yahoo.com - September 28 at 8:02 AM
finance.yahoo.com logoSAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19
finance.yahoo.com - September 24 at 8:49 AM
finance.yahoo.com logoSAB Biotherapeutics Awarded Additional $60.5M from BARDA and U.S. Department of Defense for Rapid Response Capability and Advancing SAB-185 for Treatment of COVID-19
finance.yahoo.com - September 22 at 8:12 AM
finance.yahoo.com logoSAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza
finance.yahoo.com - September 15 at 7:46 AM
finance.yahoo.com logoSAB Biotherapeutics to Present at Upcoming September Virtual Investor Conferences
finance.yahoo.com - September 8 at 9:38 AM
barrons.com logoBig Cypress Acquisition Corp.
barrons.com - August 11 at 10:09 PM
finance.yahoo.com logoSAB Biotherapeutics Announces Nonclinical Data Demonstrating SAB-185 Potently Neutralizes Delta and Lambda SARS-CoV-2 Variants
finance.yahoo.com - August 11 at 8:08 AM
nasdaq.com logoBig Cypress Acquisition Corp. Common stock (BCYP)
nasdaq.com - August 10 at 12:31 AM
in.finance.yahoo.com logoSTMP Jul 2021 300.000 put
in.finance.yahoo.com - July 15 at 10:46 PM
finance.yahoo.com logoBig Cypress Acquisition Corp. Reports Ladenburg Conference Presentation by Planned Merger Partner SAB Biotherapeutics
finance.yahoo.com - July 15 at 7:44 AM
finance.yahoo.com logoLifshitz Law Firm, P.C. Announces Investigation of ALTA, BCYP, IKNX and STMP
finance.yahoo.com - July 10 at 4:17 PM
finance.yahoo.com logoBig Cypress Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination with SAB Biotherapeutics
finance.yahoo.com - July 7 at 8:09 AM
finance.yahoo.com logoNOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: CITIC Capital Acquisition Corp. (NYSE - CCAC), Thimble Point Acquisition Corp. (Nasdaq - THMA), Big Cypress Acquisition Corp. (Nasdaq - BCYP)
finance.yahoo.com - June 28 at 6:52 PM
feeds.benzinga.com logoSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Big Cypress Acquisition Corp. Merger
feeds.benzinga.com - June 25 at 3:58 PM
finance.yahoo.com logoSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Big Cypress Acquisition Corp. (Nasdaq - BCYP)
finance.yahoo.com - June 22 at 7:37 PM
finance.yahoo.com logoSAB Biotherapeutics to List on Nasdaq through Merger with Big Cypress Acquisition Corp., Advancing Unique Human Antibody Platform with Demonstrated Utility in Immunotherapy and Rapid Response to Emerging Diseases
finance.yahoo.com - June 22 at 9:37 AM
msn.com logoInside Primary Wave’s $1.5 Billion Hit Factory
msn.com - April 26 at 2:38 PM
msn.com logo'It was beautiful': Rancho Bonito's neighbors say action is needed to protect environment
msn.com - April 21 at 12:44 PM
bizjournals.com logoReal Estate Deals: 6x6 deal gives mid-Market a taste of Sweden
bizjournals.com - April 2 at 1:44 PM
seekingalpha.com logoHCI Group's (HCI) CEO Paresh Patel on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 12 at 10:26 PM
msn.com logoHCI Group Inc (HCI) Q4 2020 Earnings Call Transcript
msn.com - March 12 at 5:25 PM
msn.com logoXenia Hotels and Resorts (XHR) Q4 2020 Earnings Call Transcript
msn.com - March 1 at 8:23 PM
www.bloomberg.com logoBlue Calypso Announces That Federal Circuit Denies Groupon's Petition for Transfer of Patent Infringement Case
www.bloomberg.com - May 4 at 3:36 PM
www.nasdaq.com logoBlue Calypso Inc. (BCYP) After-Hours Quotes
www.nasdaq.com - February 13 at 2:56 PM
www.nasdaq.com logoBlue Calypso Inc. (BCYP) Pre-Market Quotes
www.nasdaq.com - February 13 at 12:20 AM
www.nasdaq.com logoBlue Calypso Inc. (BCYP) Revenue EPS
www.nasdaq.com - February 12 at 7:20 PM
www.nasdaq.com logoBlue Calypso Inc. (BCYP) Earnings Report Date
www.nasdaq.com - February 12 at 7:20 PM
Get Big Cypress Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCYP and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.